31 completed, 21 recruiting, 7 active not recruiting, 7 unknown. 17 Not applicable, 11 Phase 1, 9 Phase 2, 6 Phase 3, 3 Early Phase 1.
Follow Hepatolenticular Degeneration: new trials by email Literature Review of Hepatolenticular Degeneration trials Research Report on Hepatolenticular Degeneration
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients. TETA 4HCl formulation, D-Penicillamine - Wilson's Disease | Phase 3 | Recruiting | Orphalan | 38 | 2026-09-03 | 2026-10-15 |
| A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD) PM577a - Wilson Disease, Wilson's Disease | Phase 1 / Phase 2 | Recruiting | Prime Medicine, Inc. | 42 | 2026-09-01 | 2026-10-01 |
| Description of Renal Involvement in Wilson's Disease full renal workup - Wilson Disease | Recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 150 | 2026-07-22 | 2026-10-01 | |
| Endocrine Dysfunction in Pediatric Wilson's Disease Wilson's Disease | Not yet recruiting | Assiut University | 30 | 2026-06-30 | 2025-10-06 | |
| Phase I/II Clinical Study to Evaluate the Safety, Tolerability and Efficacy of LY-M003 Injection in Adult Patients With Wilson's Disease LY-M003 Injection - Wilson's Disease | Phase 1 / Phase 2 | Not yet recruiting | Lingyi Biotech Co., Ltd. | 18 | 2026-06-15 | 2026-07-02 |
| Evaluation of the Safety, Tolerability, and Efficacy of GC310 Injection in Patients With Wilson's Disease (WD) GC310 - Wilson Disease | Phase 1 / Phase 2 | Recruiting | GeneCradle Inc | 15 | 2026-02-20 | 2026-11-17 |
| Off Treatment Urinary Copper Excretion in Wilson Disease, Pilot Study Wilson Disease | Recruiting | Yale University | 30 | 2026-01-08 | 2026-03-05 | |
| A Clinical Study on the Treatment of Wilson Disease With ATP7B mRNA/LNP (DSL101) Group 1: DSL101 Low dose, Group 2: DSL101 Medium dose, Group 3: DSL101 High dose - Wilsons Disease | Early Phase 1 | Recruiting | DSciLab Co., Ltd. | 18 | 2025-12-31 | 2026-01-20 |
| Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical Trial Wilson Disease | Active not recruiting | Prime Medicine, Inc. | 30 | 2025-12-29 | 2026-05-12 | |
| Multifaceted Assessment of Patients With Wilson's Disease in a Low-Resource Setting in Upper Egypt: Service Integration, Psychosocial Burden, Dietary Practices, and the Geo-Spatial Disease Map KAB-pB Scores - Wilson's Disease | Not yet recruiting | Assiut University | 66 | 2025-12-01 | 2025-11-21 | |
| Wilson's Disease Treated With D-Penicillamine: Characterization of Skin Damage Secondary to Treatment by Measuring Skin Elasticity Preparation of forearm molds with SILFLO® silicone - Wilson Disease, D-Penicillamine | Not applicable | Recruiting | Centre Hospitalier Universitaire de Saint Etienne | 120 | 2025-11-28 | 2026-01-23 |
| Subclinical Myocardial Dysfunction in Children With Wilson's Disease Echocardiography, Electrocardiography, N-terminal pro b- type natriuretic peptide - Wilson's Disease, Myocardial Dysfunction | Active not recruiting | Hebatullah Fawzy | 72 | 2025-10-01 | 2026-08-14 | |
| Patient Preference Study: Standard of Care Versus Once-daily Trientine Tetrahydrochloride New TETA 4HCl Formulation, Standard of Care - Wilson's Disease | Phase 2 | Completed | Orphalan | 10 | 2025-07-15 | 2026-04-06 |
| Gene Therapy for Wilson Disease Evaluated by 64Cu PET/CT Wilson Disease | Enrolling by invitation | Thomas Damgaard Sandahl | 5 | 2025-07-08 | 2025-09-08 | |
| Circadian Variation of Urinary Copper Excretion in Wilson Disease Patients urine and blood test - Wilson Disease | Recruiting | Hospices Civils de Lyon | 30 | 2025-01-10 | 2026-01-15 | |
| Daily Versus Alternate Day Plasma Exchange in Wilson Disease With Acute Liver Failure in Children Plasma Exchange, Standard Medical Treatment - Acute Liver Failure, Wilson Disease | Not applicable | Not yet recruiting | Institute of Liver and Biliary Sciences, India | 20 | 2024-11-10 | 2024-11-21 |
| An Exploratory Study to Evaluate the Tolerability and Safety of MWAV201 in Subjects With Wilson Disease MWAV201 - Wilson Disease | Not applicable | Active not recruiting | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 9 | 2024-10-28 | 2026-08-12 |
| A Clinical Study to Evaluate the Safety and Efficacy of LY-M003 Injection in Patients With Wilson Disease LY-M003 - Wilson Disease | Early Phase 1 | Recruiting | Chaohui Yu | 18 | 2024-09-24 | 2026-01-23 |
| The Exploratory Handheld Optical Coherence Tomography Study in Wilson's Disease Diagnostic procedures - Wilson Disease | Not applicable | Completed | Royal Surrey County Hospital NHS Foundation Trust | 10 | 2024-08-02 | 2025-07-01 |
| Institutional Registry of Rare Diseases Rare Diseases, Amyloidosis | Recruiting | Hospital Italiano de Buenos Aires | 380 | 2024-07-01 | 2026-01-14 |
Showing 20 of 79. Sign in to see all of them.
Metabolism, Inborn Errors (4) · Rare Diseases (4) · Dystonia (3) · Genetic Diseases, Inborn (3) · Leukodystrophy, Metachromatic (3) · Ornithine Carbamoyltransferase Deficiency Disease (3) · 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency (2) · Acidemia, isovaleric (2) · Adrenal Hyperplasia, Congenital (2) · Adrenoleukodystrophy (2) · Anemia, Sickle Cell (2) · Argininosuccinic Aciduria (2) · Ataxia with vitamin E deficiency (2) · Basal ganglia disease, biotin-responsive (2)
Basal Ganglia Diseases (79) · Brain Diseases (79) · Brain Diseases, Metabolic (79) · Brain Diseases, Metabolic, Inborn (79) · Central Nervous System Diseases (79) · Digestive System Diseases (79) · Heredodegenerative Disorders, Nervous System (79) · Neurodegenerative Diseases (79) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (78) · Liver Diseases (78) · Metal Metabolism, Inborn Errors (78) · Nervous System Diseases (78) · Nutritional and Metabolic Diseases (78) · Metabolic Diseases (77) · Movement Disorders (77)
tetrathiomolybdate (6) · Trientine (5) · Standard of Care (4) · Penicillamine (3) · Hematologic Tests (2) · gluconic acid (2) · Botulinum Toxins, Type A (1) · Bupropion (1) · Celecoxib (1) · Diagnostic Imaging (1) · Diagnostic Techniques and Procedures (1) · Echocardiography (1) · Electrocardiography (1) · Galactose (1) · Genetic Testing (1)
Alexion Pharmaceuticals, Inc. (11) · Fondation Ophtalmologique Adolphe de Rothschild (7) · Orphalan (6) · Assiut University (4) · Second Affiliated Hospital, Zhejiang University, School of Medicine (3) · Ultragenyx Pharmaceutical Inc (3) · Yale University (3) · Assistance Publique - Hôpitaux de Paris (2) · Hospices Civils de Lyon (2) · National Center for Research Resources (NCRR) (2) · Prime Medicine, Inc. (2) · Univar BV (2) · Asociación Española para el Estudio del Hígado (1) · Beijing Friendship Hospital (1) · CENTOGENE GmbH Rostock (1)
United States (23) · France (17) · United Kingdom (17) · China (15) · Germany (11) · Spain (8) · Denmark (6) · Poland (6) · Canada (4) · New Zealand (4) · Austria (3) · Belgium (3) · Italy (3) · Turkey (Türkiye) (3) · Australia (2)
Eugene S. Swenson, MD, PhD (4) · Chaohui Yu, PhD (2) · George J. Brewer (2) · Adrian Gadano, MD (1) · Andres Lozano, MD (1) · Anna Davidsson (1) · Arndt Rolfs, Prof. Dr. (1) · Chinchang Huange, Doctor (1) · Curt Scharfe, MD, PhD (1) · Eduardo Jorge Premoli, MD (1)
PMID 21078496, PMID 22340672, PMID 25605552, PMID 28747452, PMID 28753182, PMID 28988934, PMID 30241550, PMID 30691535, PMID 31315600, PMID 31947878, PMID 32651242, PMID 34162411, PMID 34286869, PMID 34572285, PMID 35142618, PMID 35482910, PMID 35668470, PMID 35995551, PMID 36183738, PMID 37722831, PMID 37782421, PMID 38397079, PMID 38660122, PMID 39139457, PMID 39468897, PMID 40089450, PMID 40104015, PMID 40538652, PMID 41667276, PMID 41831608
2017 (1), 2018 (1), 2019 (1), 2025 (1), R01DK137861 (1)